The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Drug-coated balloon: state of the art 2010

How to use the drug-eluting balloon: recommendations by the German consensus group

EuroIntervention 2011;7:K125-K128.


The drug eluting balloon (DEB) has demonstrated safety and efficacy for treatment of restenosed and de novo lesions in coronary artery disease in several clinical trials. Late lumen loss at follow-up is consistently low (~0.2mm), and no thrombotic event has been reported when using the DEB (Sequent®Please) as a stand-alone therapy.

Some issues remain when combining the DEB with a bare metal stent (BMS), since geographic mismatch (DEB does not cover total stented area) between DEB and BMS can not always be avoided. The combination of the DEB with a BMS further results in a somewhat ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Tools & Techniques: PCI in coronary bifurcations lesions